Author:
D'Almeida Mark S.,Lautt W. Wayne
Abstract
Glucagon, in the anesthetized cat, was capable of dilating the hepatic artery to the same extent and in a dose-dependent manner when administered directly into the hepatic artery or into the portal vein. Portal venous infusions of glucagon did not inhibit nerve- or norepinephrine-induced vasoconstriction of the hepatic artery in contrast to previous reports in the dog. Rather, at certain doses, glucagon mildly potentiated the vasoconstriction induced by both constrictor stimuli. Vascular escape from nerve- and norepinephrine-induced constrictor responses was found to be inhibited by glucagon in a dose-dependent manner. Glucagon infusion is the first intervention reported to modulate vascular escape in the hepatic artery. Owing to its similar effects on nerve- and exogenous norepinephrine-induced responses, glucagon appears to be acting at a postsynaptic site. Therefore, we suggest that in the cat, glucagon is not an inhibitory modulator of nerve- and norepinephrine-induced vasoconstriction, but rather may potentiate the constrictor response in a postsynaptic manner.Key words: glucagon, hepatic artery, modulation, vascular escape, vasoconstriction.
Publisher
Canadian Science Publishing
Subject
Physiology (medical),Pharmacology,General Medicine,Physiology
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hepatic Circulation;Colloquium Series on Integrated Systems Physiology: From Molecule to Function;2009-01
2. Nitric oxide mediates hepatic arterial vascular escape from norepinephrine-induced constriction;American Journal of Physiology-Gastrointestinal and Liver Physiology;1999-12-01
3. The Place of Glucagon in Emergency Medicine;Glucagon III;1996
4. Glucagon in portal hypertension;Journal of Hepatology;1994-01
5. Cardiovascular emergencies;Glucagon in Acute Medicine;1993